- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
December 29th, 2006
An Indian-American scientist has won a USD 4.1 million award given by the US Department of Defence (DoD) for breast cancer research.
His recent work brought together cancer biology, pharmacology and engineering to create an anti-cancer drug delivery device dubbed the nanocell. This technology has the potential to eliminate the systemic toxicity caused by chemotherapy by directing drugs to act only where they are needed. The concept is now being commercialised by Tempo Pharmaceuticals, which is a MIT start-up.
|Related News Press|
Simple attraction: Researchers control protein release from nanoparticles without encapsulation: U of T Engineering discovery stands to improve reliability and fabrication process for treatments to conditions such as spinal cord damage and stroke May 28th, 2016
Nanoscale Trojan horses treat inflammation May 24th, 2016
Doubling down on Schrödinger's cat May 27th, 2016
Deep Space Industries and SFL selected to provide satellites for HawkEye 360’s Pathfinder mission: The privately-funded space-based global wireless signal monitoring system will be developed by Deep Space Industries and UTIAS Space Flight Laboratory May 26th, 2016
Are humans the new supercomputer?Today, people of all backgrounds can contribute to solving serious scientific problems by playing computer games. A Danish research group has extended the limits of quantum physics calculations and simultaneously blurred the boundaries between mac April 14th, 2016
UCLA nanoscientists engage shoppers in fun conversations March 8th, 2016
Risk Analysis Publishes Non-Animal Strategy to Assess Nanomaterials February 24th, 2016